Bupropion Neuraxpharm

Medicinal product

(Invented) name

Bupropion Neuraxpharm

Active substance (s)

Bupropiono hidrochloridas

Strength

300 mg

Pharmaceutical form

modifikuoto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N06AX12, Bupropion

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-05-23

Date of renewal

Documents

2589_Bupropion_neuraxpharma_300mg_mod_atp_tab_PIL_2025-05-23.docx

2589_Bupropion_neuraxpharma_300mg_mod_atp_tab_PZ_2025-05-23.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Bupropiono hidrochloridas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117648	103751	1103751	lizdinė plokštelė	N30		Receptinis	LT/L/25/2589/001	Netiekiama	-	2025-09-30	No	-	-	Download

Stadijos

Data	Stadija
2025-05-23	Registruotas